浸润性乳腺癌

  • 网络invasive breast cancer;Invasive breast carcinoma
浸润性乳腺癌浸润性乳腺癌
  1. 浸润性乳腺癌组织中整合素β1和ki-67的表达及其意义

    Expression and Significance of Beta 1 Integrin and ki-67 in Invasive Breast Cancer

  2. 浸润性乳腺癌、非浸润性乳腺癌及正常乳腺组织对照组中p53的阳性率分别是71.6%、30.8%和0%;

    Results : ( 1 ) The positive rates of p53 in invasive breast cancer , noninvasive breast cancer and normal breast tissue are 71.6 % , 30.8 % and 0 % , respectively .

  3. 结果:MRI对于浸润性乳腺癌具有高度的敏感性。

    Result : The sensitivity of MRI was remarkably higher to infiltrative mammary cancer .

  4. 浸润性乳腺癌中TRAIL及survivin的表达及意义

    Expression of TRAIL and survivin in invasive breast carcinoma and its significance

  5. 浸润性乳腺癌中c-myc,Bcl-2蛋白表达及DNA倍性的检测及意义

    The detection of c-myc , Bcl-2 protein and DNA ploidy in invasive breast carcinoma and its significance

  6. 基底细胞样型浸润性乳腺癌中PTEN、p53、Ki-67的表达及意义

    Expression and significance of PTEN , p53 and Ki-67 in basal-like invasive breast carcinoma

  7. 北京市住院女性浸润性乳腺癌HER-2受体状态特征分析

    Characteristic of HER-2 in Beijing inpatients with invasive breast cancer

  8. 目的探讨浸润性乳腺癌中cMyc,Bcl2蛋白表达及DNA倍性与乳腺癌患者预后的关系。

    Objective To investigate the clinical significance of c-myc 、 Bcl-2 protein expression , DNA ploidy and their relationship in breast cancer .

  9. P-gp、LRP在浸润性乳腺癌中表达的临床意义

    The Clinical Significance of P-glycoprotein and Lung Resistance Protein Expressions in Infiltrating Breast Carcinoma Tissues

  10. 浸润性乳腺癌中PTEN表达与组织学分级、腋淋巴结转移、TNM分期、微血管密度计数均呈显著负相关。

    The expression of PTEN was negatively correlated to histological grading , axillary lymph node metastasis , clinical staging and MVD .

  11. 浸润性乳腺癌中PTEN的表达低于非浸润性乳腺癌及非肿瘤病变组织对照组(P<0.01)。

    The positive rates of PTEN in invasive cancer were lower than noninvasive breast cancer and the control group ( P < 0.01 ) .

  12. 方法:用LSAB法检测浸润性乳腺癌(IBC)中的微血管数(MVC)和pS2表达。

    Methods By LSAB immunohistochemistry , MVC and pS2 expression in invasive breast cancer ( IBC ) were detected .

  13. 浸润性乳腺癌及乳腺增生细胞3p、9p上5个微卫星位点的杂合性缺失观察

    Loss of heterozygosity of microdissected invasive on 3p , 9p in ductal carcinoma of breast and hyperplastic breast lesions

  14. 使用ELISA技术检测其中9例乳腺良性病变、29例浸润性乳腺癌患者术前血清MMP-9和TIMP-1的蛋白浓度。

    Among those cases , the preoperative serum concentrations of MMP-9 and TIMP-1 were detected by sandwich ELISA technique in 9 cases of breast benign diseases and 29 cases of breast infiltrating carcinoma .

  15. 方法采用组织芯片平台,应用免疫组织化学方法结合计算机图像分析技术检测160例浸润性乳腺癌组织MMP-2、MMP-9、TIMP-1和TIMP-2蛋白表达及其相应比值大小。

    Methods The expression of proteins MMP-2 , MMP-9 , TIMP-1 , and TIMP-2 was examined by immunohistochemistry S-P in 160 cases of infiltrating carcinoma tissues on tissue chip platform .

  16. 目的对浸润性乳腺癌的钼靶X线表现与雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2(HER2)的表达状况进行比较,分析其相关性。

    Objective To verify the correlation between mammographic features and expression of estrogen receptor ( ER ), progesterone receptor ( PR ) and human epidermal growth factor receptor 2 ( HER2 ) in invasive breast cancer .

  17. 检测67例浸润性乳腺癌中VEGF、MMP-9及TIMP-1蛋白的表达,并采用CD34标记血管内皮细胞,进行MVD计数。

    Meanwhile , the expression of VEGF , MMP-9 , TIMP-1 was detected in 67 cases of breast cancer and microvessel density values were also counted in infiltrating carcinomas , for which vascular endothelium marker CD34 antigen was used .

  18. 在乳腺导管内原位癌中表达阳性率为55.0%(11/20),浸润性乳腺癌中为85.0%(51/60);HIF-1α表达与淋巴结转移及雌激素受体状态有关(P0.01)。

    However , the positive expression rate of HIF-1 α in the ductal carcinoma in situ ( DCIS ) was 55.0 % ( 11 / 20 ) and the infiltrative breast cancer was 85.0 % ( 51 / 60 ) .

  19. 虽然Survivin蛋白和Livin蛋白在浸润性乳腺癌组织中均呈高表达,但二者之间无明显相关,提示二者在浸润性乳腺癌组织中表达的上调机制有所不同。

    Despite of the high expression of Survivin and Livin in invasive breast cancer tissues , there was no significant correlation between them , suggesting that the increased mechanism of Survivin and Livin is different in invasive breast cancer .

  20. 据报道,由于浸润性乳腺癌和心血管疾病危险性的增加,美国国立卫生研究院提前三年结束了已经进行了5.2年的HRT在健康绝经妇女更年期综合征的临床试验。

    Recently , the American National Institute of Health stopped a clinical trial with HRT in healthy postmenopausal women after 5.2 years more than 3 years earlier than planned due to an increased risk of invasive breast cancer and of cardiovascular risks .

  21. 192例浸润性乳腺癌导管内扩散及预后因素分析

    Study of prognostic factors in invasive breast carcinoma : intraductal spread

  22. 浸润性乳腺癌近似分子亚型的临床意义

    Clinical Significance of Approximated Molecular Subtypes of Invasive Breast Cancer

  23. 化疗已成为浸润性乳腺癌的主要疗法之一。

    Chemotherapy has became one principal method to therapy invasive breast cancer .

  24. 微血管量在浸润性乳腺癌中的意义

    The value of microvessel density in invasive breast carcinoma

  25. 浸润性乳腺癌预后的多因素分析

    Multifactor analysis on the prognosis of invasive breast cancer

  26. 浸润性乳腺癌组织上皮钙依赖粘附素相关分子的表达

    Expression of E-cadherin associated molecule in invasive breast carcinoma

  27. 结论:对早期浸润性乳腺癌妇女,使用辅助治疗还是有益的。

    Conclusion : The adjuvant treatment of patients with primary invasive breast cancer is beneficial .

  28. 女性原发浸润性乳腺癌淋巴结转移水平与预后观察

    The Observation on Lymph Node Metastasis and Prognosis of the Primary Infiltrating Breast Cancer in Women

  29. 浸润性乳腺癌高频超声显像肿瘤大小、边界与腋窝淋巴结发生转移密切相关。

    The size , border of infiltrative breast cancer has close correlation with axillary lymph node metastases .

  30. 目前浸润性乳腺癌的外科治疗是全乳腺切除或区段切除,加腋淋巴结清扫。

    Now surgery therapy of infiltration breast cancer is whole or partical breast dissection , and axillary lymphnode dissection .